Keith H. Ansell
Keith H. Ansell publishes mostly in Public Health, Environmental and Occupational Health, Molecular Biology and Epidemiology, on topics such as Malaria Research and Control, Trypanosoma species research and implications and Research on Leishmaniasis Studies.
- World rank
- #1,660,902 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #125,584 of 367,258
- Works
- 25
- Citations
- 1.4k
- Citations per work
- 57.0
What does Keith H. Ansell research?
Keith H. Ansell's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1039.7%
- Medicine1039.7%
- Everything else726.5%
- Life Sciences623.5%
- Physical Sciences310.3%
- Computer Science15.9%
- Chemistry14.4%
- 1Public Health, Environmental and Occupational Health29% of their works
- 2Molecular Biology18% of their works
- 3Epidemiology10% of their works
- 4Computational Theory and Mathematics6% of their works
- 5Immunology6% of their works
- 6Organic Chemistry4% of their works
Research topics
- Malaria Research and Control
- Trypanosoma species research and implications
- Research on Leishmaniasis Studies
- Mosquito-borne diseases and control
- Computational Drug Discovery Methods
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Keith H. Ansell's research?
The keywords of their largest research topics: Epidemiology, Vaccine Development, Genome Sequence, Artemisinin Resistance, Plasmodium falciparum, Drug Resistance, Vector Control and Chagas Disease.
- Phenothiazines
- Glycans
- Biological Activities
- Molecular Docking
- Arboviral Diseases
- Treatment
- Chagas Disease
- Drug Resistance
- Artemisinin Resistance
- Vaccine Development
- Epidemiology
- Genome Sequence
- Plasmodium falciparum
- Vector Control
- Leishmaniasis
- Trypanosoma cruzi
- Zika Virus
- Virtual Screening
- Biopharmaceuticals
- Glycosylation
- Protein Aggregation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology254 topics
- Vaccine Development203 topics
- Genome Sequence162 topics
- Artemisinin Resistance111 topic
- Plasmodium falciparum111 topic
- Drug Resistance102 topics
- Vector Control92 topics
- Chagas Disease51 topic
- Leishmaniasis51 topic
- Treatment51 topic
- Trypanosoma cruzi51 topic
- Arboviral Diseases41 topic
- Zika Virus41 topic
- Molecular Docking31 topic
- Virtual Screening31 topic
- Biological Activities21 topic
- Biopharmaceuticals21 topic
- Glycans21 topic
- Glycosylation21 topic
- Phenothiazines21 topic
- Protein Aggregation21 topic
Where does Keith H. Ansell work?
Keith H. Ansell's main affiliation in the publication record is LifeArc, United Kingdom.
How many publications and citations does Keith H. Ansell have?
OpenAlex counts 25 works and 1,426 citations for Keith H. Ansell, an h-index of 17, ranking #1,660,902 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Keith H. Ansell. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.